Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Verrica Pharmaceuticals Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17Dec-31-16
Revenues0.00.01.7
            Revenue growth -100.0% 
Cost of goods sold0.00.01.9
Gross profit0.00.0-0.2
            Gross margin  -11.9%
Research and development12.83.7 
General and administrative9.10.70.2
EBIT-21.9-4.5-1.9
            EBIT margin  -111.9%
Pre-tax income-20.6-4.5-1.9
Income taxes0.00.00.0
            Tax rate0.0%0.0%0.0%
Net income-20.6-9.80.0
            Net margin  -0.1%
 
Diluted EPS($1.41)($3.42)($0.52)
Shares outstanding (diluted)14.72.90.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy